Constantine Charoglu, MD
Hand Surgery · Hattiesburg, MSNPI 1255360186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Boston Scientific at 39.5% of the total. Reporting peaked in 2022 at $156 and has fallen 66.4% since, to $53 in 2025.
Across 15 payments — averaging $28.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$169
- Johnson & Johnson$127
- ALON Medical Technology$70
- Skeletal Dynamics Inc$30
- Vertex$18
- Mallinckrodt Enterprises LLC$14
Across 2 payments — averaging $584.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$1K
What the payments were for
- Food & beverage$427100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $169 |
| Johnson & Johnson(2 entities) | 3 | $127 |
| ALON Medical Technology | 2 | $70 |
| Skeletal Dynamics Inc | 2 | $30 |
| Vertex | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
How this compares
Too few hand surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $484 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 84 | $340 |
| Diclofenac Sodium | 20 | $312 |
| Ondansetron Hcl | 93 | $304 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $192 |
| Tramadol Hcl | 56 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $71 |
| Meloxicam | 11 | $31 |
| Famotidine | 35 | $14 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Hattiesburg
- Rocco BarbieriHattiesburg$989
- William GeisslerJackson$1.8M
- William WellerSouthaven$13K
- Michael VollantJackson$12K
- Sean FarrellTupelo$2K
- Tyler MarksTupelo$2K
- Chris EthridgeJackson$489
- Aubrey LucasFlowood$78
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.